This post was written by Paul Sheives. The GAO issued a report entitled “Oversight of Clinical Investigators: Action Needed to Improve Timeliness and Enhance Scope of FDA’s Debarment and Disqualification Processes for Medical Product Investigators.”   Among other things, the report raises concerns about the length of time associated with FDA disqualification proceedings. The